Related Experiment Video
Updated: May 21, 2025
08:55
Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials
Published on: June 25, 2018
8.0K
Antitumor potential of polyamines in cancer
He Liu1,2,3,4,5, Yi Liu1,2,3,4,5, Xinyue Wang1,2,3,4,5
1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Acta Biochimica Et Biophysica Sinica
|March 19, 2025
Summary
Altered polyamine metabolism in tumors offers new cancer treatment avenues. Inhibiting polyamine pathways and using polyamine supplements show promise for effective cancer therapies.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Polyamines are crucial for cell growth and proliferation.
- Dysregulated polyamine metabolism is a hallmark of many cancers.
- Gene mutations significantly alter polyamine metabolism in tumor cells.
Purpose of the Study:
- To explore polyamine metabolism as a therapeutic target in cancer.
- To review current and emerging strategies for targeting polyamine pathways.
- To investigate the potential of polyamine-based combination therapies.
Main Methods:
- Review of preclinical and clinical studies on polyamine metabolism in cancer.
- Analysis of drug development targeting polyamine biosynthesis and transport.
- Examination of the role of polyamines in cancer signaling pathways.
Main Results:
- Inhibiting polyamine biosynthesis and transport shows antitumor effects.
- Several drugs targeting polyamine metabolism are in clinical trials.
- Polyamines influence cancer signaling pathways, enabling combination therapies.
- Supplemental polyamines exhibit antitumor activity.
Conclusions:
- Targeting polyamine metabolism is a promising strategy for cancer therapy.
- Combination therapies involving polyamines may enhance clinical benefits.
- Further research into polyamine metabolism can lead to novel anticancer treatments.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:12Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K